Herein, we constructed a prognostic risk signature with four ICDGs (HMGN1, BCL2, HSP90AA1, AGER) by LASSO Cox regression approach, which divided HNSCC patients into two cohorts as per the risk score calculated by this model. This evidence concerns the gene HMGN1 and head and neck squamous cell carcinoma.